Financial Data
- Financial Highlights
- Financial
Position /
Cash Flows - Sales by Product
and Area - Consolidated Financial Statements
Consolidated Financial Statements
Consolidated Balance Sheets
Millons of yen, rounded down
| FY2022/3 | FY2023/3 | FY2024/3 | FY2025/3 | FY2026/3 | |
|---|---|---|---|---|---|
| Assets | |||||
| Current assets | |||||
| Cash and deposits | 35,005 | 32,167 | 44,295 | 56,755 | 51,548 |
| Notes and accounts receivable - trade | - | - | - | - | - |
| Notes | 750 | 715 | 922 | 888 | 885 |
| Accounts receivable - trade | 31,832 | 36,405 | 53,196 | 40,730 | 42,947 |
| Securities | 23,999 | - | - | - | - |
| Inventories | 18,001 | 23,352 | 22,208 | 25,136 | 29,092 |
| Other | 5,588 | 6,439 | 7,309 | 10,449 | 7,386 |
| Allowance for doubtful accounts | (6) | (110) | (78) | (122) | (174) |
| Total current assets | 115,171 | 98,970 | 127,853 | 133,837 | 131,684 |
| Non-current assets | |||||
| Property, plant and equipment | 82,979 | 101,533 | 123,657 | 145,782 | 155,463 |
| Buildings and structures | 34,020 | 34,574 | 38,670 | 70,285 | 73,598 |
| Machinery, equipment and vehicles | 33,824 | 31,758 | 36,500 | 49,049 | 52,827 |
| Land | 11,977 | 16,330 | 16,265 | 16,226 | 21,331 |
| Leased assets | 458 | 480 | 534 | 596 | 1,174 |
| Construction in progress | 1,255 | 16,796 | 29,851 | 7,194 | 4,048 |
| Other | 1,442 | 1,593 | 1,835 | 2,429 | 2,482 |
| Intangible assets | 26,079 | 25,932 | 25,271 | 24,207 | 24,745 |
| Goodwill | 23,550 | 23,222 | 22,650 | 20,548 | 20,987 |
| Other | 2,529 | 2,709 | 2,620 | 3,659 | 3,757 |
| Investments and other assets | 12,368 | 12,658 | 15,376 | 15,340 | 15,715 |
| Investment securities | 2,408 | 2,597 | 3,183 | 3,263 | 2,987 |
| Long-term loans receivable | 100 | 100 | - | - | - |
| Deferred tax assets | 5,178 | 4,955 | 5,408 | 5,064 | 4,481 |
| Retirement benefit asset | 2,895 | 3,434 | 4,505 | 5,202 | 6,197 |
| Other | 1,785 | 1,572 | 2,280 | 1,810 | 2,061 |
| Allowance for doubtful accounts | (1) | (1) | (1) | (1) | (12) |
| Total non-current assets | 121,427 | 140,124 | 164,305 | 185,331 | 195,924 |
| Total assets | 236,598 | 239,095 | 292,158 | 319,169 | 327,609 |
| Liabilities | |||||
| Current liabilities | |||||
| Notes and accounts payable - trade | 11,849 | 13,553 | 12,535 | 13,358 | 14,739 |
| Short-term loans payable | 1,447 | 1,290 | 1,433 | 883 | 1,766 |
| Current portion of long-term loans payable | - | - | - | - | 10,000 |
| Lease obligations | 160 | 156 | 169 | 203 | 399 |
| Accounts payable - other | 8,229 | 8,441 | 11,736 | 13,588 | 10,945 |
| Income taxes payable | 4,242 | 3,702 | 6,743 | 3,829 | 4,154 |
| Provision for bonuses | 4,625 | 5,398 | 6,606 | 6,456 | 5,860 |
| Provision for bonuses for directors (and other officers) | 93 | 99 | 116 | 153 | 159 |
| Provision for stocks payment | 45 | 37 | 98 | 105 | 43 |
| Other | 11,565 | 12,983 | 15,035 | 17,126 | 16,871 |
| Total current liabilities | 42,259 | 45,663 | 54,475 | 55,705 | 64,941 |
| Non-current liabilities | |||||
| Long-term loans payable | - | - | 25,000 | 35,000 | 25,000 |
| Lease obligations | 375 | 403 | 433 | 468 | 872 |
| Deferred tax liabilities | 906 | 1,287 | 1,854 | 1,903 | 2,417 |
| Provisions for retirement benefits for directors (and other officers) | 334 | 323 | 100 | 98 | 125 |
| Provision for management board incentive plan trust | 323 | 297 | 280 | 297 | 294 |
| Retirement benefit liability | 8,049 | 7,523 | 8,017 | 8,853 | 8,687 |
| Asset retirement obligations | 749 | 748 | 755 | 1,545 | 3,272 |
| Other | 142 | 163 | 155 | 229 | 224 |
| Total non-current liabilities | 10,881 | 10,745 | 36,596 | 48,396 | 40,894 |
| Total liabilities | 53,140 | 56,408 | 91,072 | 104,101 | 105,835 |
| Net assets | |||||
| Shareholders' equity | |||||
| Capital stock | 12,046 | 12,046 | 12,046 | 12,046 | 12,046 |
| Capital surplus | 3,232 | 3,242 | 2,514 | 2,514 | 2,514 |
| Retained earnings | 170,284 | 178,329 | 191,706 | 205,571 | 215,641 |
| Treasury shares | (12,959) | (24,886) | (24,972) | (24,783) | (34,668) |
| Total shareholders' equity | 172,604 | 168,730 | 181,293 | 195,348 | 195,533 |
| Accumulated other comprehensive income | |||||
| Valuation difference on available-for-sales securities | 436 | 488 | 796 | 616 | 653 |
| Foreign currency translation adjustment | 3,232 | 5,225 | 9,751 | 9,372 | 13,601 |
| Remeasurements of defined benefit plans | (893) | (332) | (89) | (158) | (814) |
| Total accumulated other comprehensive income | 2,775 | 5,381 | 10,457 | 9,831 | 15,069 |
| Non-controlling interests | 8,078 | 8,574 | 9,335 | 9,887 | 11,171 |
| Total net assets | 183,458 | 182,686 | 201,086 | 215,067 | 221,774 |
| Total liabilities and net assets | 236,598 | 239,095 | 292,158 | 319,169 | 327,609 |
Consolidated Statements of Income
Millons of yen, rounded down
| FY2021/3 | FY2022/3 | FY2023/3 | FY2024/3 | FY2025/3 | FY2026/3 | |
|---|---|---|---|---|---|---|
| Net sales | 266,745 | 245,419 | 279,315 | 303,027 | 322,564 | 340,151 |
| Cost of sales | 148,935 | 161,465 | 189,115 | 201,068 | 212,686 | 229,346 |
| Gross profit | 117,810 | 83,954 | 90,200 | 101,959 | 109,878 | 110,804 |
| Selling, general and administrative expenses | 90,746 | 58,818 | 67,967 | 74,654 | 80,812 | 84,630 |
| Operating profit | 27,064 | 25,135 | 22,233 | 27,304 | 29,066 | 26,173 |
| Non-operating income | ||||||
| Interest income | 89 | 84 | 140 | 445 | 494 | 453 |
| Dividend income | 42 | 39 | 39 | 43 | 43 | 37 |
| Share of profit of entities accounted for using equity method | 39 | 19 | 25 | 17 | 16 | 23 |
| Foreign exchange gains | 452 | 1,712 | 1,125 | 3,509 | - | 387 |
| Other | 305 | 242 | 263 | 360 | 929 | 591 |
| Total non-operating income | 928 | 2,098 | 1,594 | 4,376 | 1,484 | 1,494 |
| Non-operating expenses | ||||||
| Interest expenses | 100 | 99 | 162 | 250 | 357 | 388 |
| Share of loss of entities accounted for using equity method | 143 | - | 1 | - | - | - |
| Foreign exchange losses | - | - | - | - | 203 | - |
| Other | 226 | 195 | 202 | 274 | 145 | 187 |
| Total non-operating expenses | 470 | 295 | 366 | 525 | 705 | 575 |
| Ordinary profit | 27,522 | 26,938 | 23,460 | 31,155 | 29,844 | 27,091 |
| Extraordinary income | ||||||
| Gain on sales of non-current assets | 14 | 6 | 14 | 7 | 2 | 12 |
| Gain on sales of investment securities | 62 | 69 | 54 | 75 | 150 | 302 |
| Other | 554 | 467 | 267 | 166 | 66 | 133 |
| Total extraordinary income | 631 | 542 | 336 | 250 | 219 | 448 |
| Extraordinary losses | ||||||
| Loss on sales of non-current assets | 57 | 23 | 35 | 236 | 4 | 19 |
| Loss on retirement of non-current assets | 559 | 407 | 491 | 372 | 437 | 715 |
| Impairment loss | - | - | 610 | 377 | 17 | 15 |
| Other | 1,155 | 302 | 18 | 215 | 207 | 599 |
| Total extraordinary losses | 1,771 | 733 | 1,155 | 1,201 | 666 | 1,350 |
| Profit before income taxes | 26,381 | 26,748 | 22,641 | 30,204 | 29,397 | 26,189 |
| Income taxes - current | 8,248 | 8,024 | 7,451 | 10,128 | 7,384 | 8,103 |
| Income taxes - deferred | 67 | 445 | 216 | (389) | 507 | 510 |
| Profit | 18,065 | 18,277 | 14,973 | 20,465 | 21,505 | 17,574 |
| Profit(loss) attributable to non-controlling interests | 383 | 224 | 201 | 579 | 631 | 245 |
| Profit attributable to owners of parent | 17,682 | 18,053 | 14,772 | 19,886 | 20,874 | 17,329 |
Consolidated Statements of Cash Flows
Millons of yen, rounded down
| FY2022/3 | FY2023/3 | FY2024/3 | FY2025/3 | FY2026/3 | |
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Profit before income taxes | 26,748 | 22,641 | 30,204 | 29,397 | 26,189 |
| Depreciation | 9,189 | 10,047 | 10,594 | 12,144 | 14,812 |
| Impairment loss | - | 610 | 377 | 17 | 15 |
| Amortization of goodwill | 1,819 | 1,979 | 2,081 | 2,152 | 2,281 |
| Increase (decrease) in allowance for doubtful accounts | 1 | 86 | (43) | 46 | 52 |
| Increase (decrease) in provision for bonuses | (298) | 763 | 1,185 | (151) | (628) |
| Increase (decrease) in provision for directors’ bonuses | (26) | 6 | 11 | 40 | (5) |
| Increase (decrease) in provision for stocks payment | 44 | 40 | 95 | 99 | 40 |
| Increase (decrease) in provision for management board incentive plan trust | 58 | (3) | 103 | 113 | 8 |
| Increase (decrease) in net defined benefit liability | (27) | (20) | (17) | 423 | 661 |
| Decrease (increase) in net defined benefit asset | (229) | (256) | (260) | (355) | (434) |
| Increase (decrease) in provision for directors’ retirement benefits | (23) | (11) | (223) | (1) | 26 |
| Interest and dividend income | (123) | (179) | (488) | (538) | (491) |
| Interest expenses | 99 | 162 | 250 | 357 | 388 |
| Foreign exchange losses (gains) | (2,013) | (1,341) | (2,854) | 925 | (311) |
| Gain on liquidation of business | - | - | (88) | - | - |
| Subsidy income | (67) | (58) | (78) | (65) | (89) |
| Share of loss (profit) of entities accounted for using equity method | (19) | (23) | (17) | (16) | (23) |
| Loss (gain) on sales of investment securities | (60) | (54) | (75) | (150) | (302) |
| Loss (gain) on valuation of investment securities | 76 | - | 71 | 125 | 209 |
| Loss (gain) on sales of non-current assets | 17 | 21 | 228 | 1 | 7 |
| Loss on retirement of non-current assets | 407 | 491 | 372 | 437 | 715 |
| Decrease (increase) in notes and accounts receivable - trade | (1,221) | (3,987) | (15,768) | 12,181 | (659) |
| Decrease (increase) in inventories | (2,780) | (4,915) | 1,824 | (3,102) | (3,116) |
| Increase (decrease) in notes and accounts payable - trade | 1,002 | 1,213 | (1,571) | 940 | 608 |
| Increase (decrease) in accounts receivable - other | 54 | 116 | 39 | (3,216) | 3,057 |
| Increase (decrease) in accounts payable - other | (114) | (353) | 3,401 | (465) | (898) |
| Increase (decrease) in accrued consumption taxes | 19 | 388 | 174 | (504) | 1,487 |
| Other, net | (1,282) | 110 | 1,300 | (1,879) | 127 |
| Subtotal | 31,248 | 27,473 | 30,830 | 48,959 | 43,727 |
| Interest and dividend income received | 120 | 189 | 485 | 537 | 490 |
| Interest expenses paid | (106) | (169) | (210) | (335) | (406) |
| Income taxes paid | (8,934) | (8,182) | (6,754) | (10,060) | (8,215) |
| Net cash provided by (used in) operating activities | 22,327 | 19,310 | 24,350 | 39,100 | 35,596 |
| Cash flows from investing activities | |||||
| Purchase of property, plant and equipment | (12,491) | (25,750) | (30,591) | (28,106) | (23,395) |
| Proceeds from sales of property, plant and equipment | 15 | 12 | 140 | 10 | 22 |
| Purchase of intangible assets | (1,024) | (966) | (595) | (1,407) | (1,577) |
| Purchase of securities | (26,998) | (13,998) | - | - | - |
| Proceeds from redemption of securities | 43,900 | 23,000 | - | - | - |
| Purchase of investment securities | (435) | (209) | (246) | (260) | (4) |
| Proceeds from sales of investment securities | 218 | 248 | 226 | 353 | 597 |
| Payments of loans receivable | (100) | - | - | - | - |
| Collection of loans receivable | 180 | 78 | - | 100 | - |
| Payments into time deposits | (925) | (5,243) | (11,996) | (22,221) | (20,491) |
| Proceeds from withdrawal of time deposits | 922 | 3,713 | 7,676 | 22,991 | 20,697 |
| Payments for guarantee deposits | (54) | (86) | (33) | (352) | (184) |
| Proceeds from collection of guarantee deposits | 382 | 71 | 17 | 109 | 15 |
| Purchase of shares of subsidiaries resulting in change in scope of consolidation | - | (1,555) | - | - | (2,191) |
| Proceeds from subsidy income | 52 | 58 | 78 | 65 | 89 |
| Other, net | 2 | 296 | 18 | 113 | 211 |
| Net cash provided by (used in) investing activities | 3,643 | (20,329) | (35,307) | (28,604) | (26,211) |
| Cash flows from financing activities | |||||
| Net increase (decrease) in short-term loans payable | (1,300) | (235) | 41 | (504) | 819 |
| Proceeds from long-term loans payable | 25,000 | 10,000 | - | ||
| Repayment of long-term loans payable | (3,465) | (535) | - | - | - |
| Purchase of treasury shares | (12,000) | (11,999) | (240) | (0) | (9,999) |
| Repayments of lease obligations | (67) | (201) | (159) | (150) | (456) |
| Dividends paid to non-controlling interests | (6,692) | (6,723) | (6,504) | (7,005) | (7,257) |
| Proceeds from share issuance to non-controlling shareholders | 461 | 445 | 279 | 286 | - |
| Dividends paid to non-controlling interests | (222) | (754) | (96) | (85) | (108) |
| Payments from changes in ownership interests in subsidiaries that do not result in change in scope of consolidation | (1,882) | 0 | (1,470) | - | - |
| Net cash provided by (used in) financing activities | (25,168) | (20,004) | 16,850 | 2,541 | (17,002) |
Effect of exchange rate change on cash and cash equivalents |
1,585 | 1,645 | 1,533 | 263 | 2,180 |
| Net increase (decrease) in cash and cash equivalents | 2,388 | (19,378) | 7,426 | 13,300 | (5,437) |
| Cash and cash equivalents at beginning of period | 47,282 | 49,670 | 30,292 | 37,718 | 51,019 |
| Cash and cash equivalents at end of period | 49,670 | 30,292 | 37,718 | 51,019 | 45,581 |